Related references
Note: Only part of the references are listed.Essential role of protein kinase Cδ in platelet signaling αIIbβ3 activation, and thromboxane A2 release
Daniel Yacoub et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Serial changes in platelet activation in patients with unstable angina following coronary stenting - Evaluation of the effect of clopidogrel loading dose in inhibiting platelet activation
HK Yip et al.
CIRCULATION JOURNAL (2005)
Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol
ER Olson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation
B Furie et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Platelet P-selectin facilitates atherosclerotic lesion development
PC Burger et al.
BLOOD (2003)
Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: A novel signaling mechanism in support of coronary protection
AM El-Mowafy
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor
JM Dogné et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Coronary heart disease, hypercholesterolemia, and atherosclerosis II. Misrepresented data
WE Stehbens
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2001)
Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function
JM Dogné et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2000)
Share Paper
